Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 2887
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01471717 | Study to Evaluate the Pharmacokinetics and Safety of INX-08189 Administered With VictrelisTM in Healthy Subjects | ||
| NCT00518297 | DDI HV (ATV - Merck) | ||
| NCT04036435 | Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis | ||
| NCT02142218 | Expanded Access Program With Nivolumab to Treat Melanoma | ||
| NCT04709276 | A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer | ||
| NCT00872976 | Study of Dasatinib and Bendamustine in Chronic Lymphocytic Leukemia | ||
| NCT02541643 | Expanded Access Single Named Patient Program With Elotuzumab (BMS-901608) for the Treatment of Patient R-A With Relapsed/Refractory Multiple Myeloma | ||
| NCT00651508 | Study to Evaluate KOS-1584 in Patients With Advanced or Metastatic Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) | ||
| NCT03126617 | Expanded Access to Elotuzumab (Empliciti) for Multiple Myeloma | ||
| NCT04444050 | Study to Evaluate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986331 in Healthy Participants | ||
| NCT00095394 | Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension | ||
| NCT03425331 | Biomarkers of Response to Ipilimumab and Nivolumab in First-line NSCLC | ||
| NCT01628692 | Study of Daclatasvir (BMS-790052) and Simeprevir (TMC435) in Patients With Genotype 1 Chronic Hepatitis C Virus | ||
| NCT05953402 | A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring | ||
| NCT00528372 | A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise | ||
| NCT05068609 | A Study of Nivolumab in Participants With Squamous Cell Carcinoma of the Head & Neck (SCCHN) - Patient Reported Outcomes (PRO) | ||
| NCT03241745 | A Study of Nivolumab in Selected Uterine Cancer Patients | ||
| NCT00063401 | Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer | ||
| NCT00971867 | Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Head and Neck Cancer | ||
| NCT06104644 | A Study to Evaluate Deucravacitinib in Participants With Moderate-to-Severe Plaque Psoriasis in Germany | ||
| NCT03165422 | A Real-World Study of Ipilimumab Treatment After Nivolumab Treatment in Melanoma in Japan | ||
| NCT01094795 | Safety Study of Abatacept in Sweden | ||
| NCT06050512 | Mezigdomide Plus Ixazomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma | ||
| NCT06565975 | Characteristics and Outcomes of Acute Myeloid Leukemia (AML) Patients Treated With Oral-Azacitidine Maintenance Therapy in France | ||
| NCT03978611 | A Study to Assess Safety of Relatlimab With Ipilimumab in Participants With Advanced Melanoma Who Progressed on Anti-Programmed Cell Death Protein 1 (Anti-PD-1) Treatment | ||
| NCT00704106 | Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders | ||
| NCT00569036 | Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors | ||
| NCT05177211 | Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL) | ||
| NCT03906071 | Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer | ||
| NCT00381706 | Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer | ||
| NCT02429934 | Abatacept for SLE Arthritis (IM101-330) | ||
| NCT03165409 | Cost of Adverse Events Related to How Often Follow-Up Occurs Among Patients With Cancer That Has Spread | ||
| NCT03667716 | COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. | ||
| NCT05780736 | A Study to Evaluate Nivolumab in the Treatment of Early Stage Esophageal or Gastroesophageal Cancer | ||
| NCT02872116 | Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer | ||
| NCT00788333 | Combination Study of BMS-754807 and Herceptin® in Patients With Advanced or Metastatic Her-2-positive Breast Cancer | ||
| NCT00792558 | Ascending Multiple-Dose Study of BMS-817378 in Subjects With Advanced Cancers | ||
| NCT00547521 | Phase IIIB Subcutaneous Abatacept Monotherapy Study | ||
| NCT01211821 | Effect of BMS-914392 on Pharmacokinetics of Metoprolol | ||
| NCT06712355 | Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer | ||
| NCT04208958 | Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer | ||
| NCT06499298 | Retrospective Evaluation of Nivolumab in Adjuvant Esophageal Cancer/Gastroesophageal Junction Cancer | ||
| NCT03712540 | An Investigational Study of Experimental Medication BMS-986278 Given With the Antibiotic Rifampin in Healthy Participants | ||
| NCT02966548 | Safety Study of BMS-986016 With or Without Nivolumab in Patients With Advanced Solid Tumors | ||
| NCT01129063 | Pharmacokinetic Study of Single Doses of Clopidogrel, 75 mg and 300 mg, in Healthy Subjects | ||
| NCT00935506 | Ex Vivo Human Thrombosis Chamber Study | ||
| NCT04472663 | Participant Reported Outcomes and Treatment Experiences in Kidney Cancer | ||
| NCT04151563 | A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and Chemotherapy | ||
| NCT01055652 | Drug-drug Interaction Study of Dapagliflozin With Voglibose in Japanese Type 2 Diabetes Mellitus Patients | ||
| NCT04938232 | Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL |
